Home » Alimta Has Only Slight Edge in Lung Cancer
Alimta Has Only Slight Edge in Lung Cancer
A trial evaluating the success of Alimta against non-small cell lung cancer showed that the drug only slightly slowed progression of the disease, but was no more efficient than paclitaxel.
Medpage Today
Medpage Today
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May